ConductScience.org, home

Paper38982016

Mitochondrial targeted antioxidants as potential therapy for huntington's disease.

Upadhayay S and 1 other. Pharmacol Rep, 2024. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mitochondrial targeted antioxidants as potential therapy for huntington's disease. Papers, record 38982016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38982016

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitochondrial targeted antioxidants as potential therapy for huntington's disease.
PubMed
Journal
Pharmacol Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
3.97, provisional
iCite
Revised in PubMed
2024-10-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Upadhayay SShubhamhttps://orcid.org/0000-0003-2018-8402
2Kumar PPuneethttps://orcid.org/0000-0002-7978-1043

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Huntington DiseaseMajor topic
AntioxidantsMajor topic
MitochondriaMajor topic
Neuroprotective AgentsMajor topic
Humans
Animals
Oxidative Stress

Source PubMed

References132

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,220,289Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.Mol Cell Neurosci2013https://conductscience.org/library/papers/23220289PubMed
218,607,213Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.Curr Opin Neurol2008https://conductscience.org/library/papers/18607213PubMed
330,616,867Recent advances in the therapeutic development for Huntington disease.Parkinsonism Relat Disord2019https://conductscience.org/library/papers/30616867PubMed
437,042,034Animal models of Huntington's disease and their applicability to novel drug discovery and development.Expert Opin Drug Discov2023https://conductscience.org/library/papers/37042034PubMed
535,829,908Computational insights into missense mutations in HTT gene causing Huntington's disease and its interactome networks.Ir J Med Sci2023https://conductscience.org/library/papers/35829908PubMed
635,865,413Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.Fac Rev2022https://conductscience.org/library/papers/35865413PubMed
734,319,843Emerging therapeutics in Huntington's disease.Expert Opin Emerg Drugs2021https://conductscience.org/library/papers/34319843PubMed
836,752,239The Prevalence of Huntington Disease in Asia Highlights Needs in Clinical, Genetic and Instrumental Diagnosis: A Systematic Review and Meta-Analysis.Psychiatr Danub2022https://conductscience.org/library/papers/36752239PubMed
937,269,968Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion2023https://conductscience.org/library/papers/37269968PubMed
1030,941,017Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors.Front Cell Neurosci2019https://conductscience.org/library/papers/30941017PubMed
1116,973,623Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences.J Biol Chem2006https://conductscience.org/library/papers/16973623PubMed
1230,081,095Mitochondrial permeability transition pore: a potential drug target for neurodegeneration.Drug Discov Today2018https://conductscience.org/library/papers/30081095PubMed
139,740,408Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid.Neuroscience1998https://conductscience.org/library/papers/9740408PubMed
1419,799,953Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.Neurochem Int2010https://conductscience.org/library/papers/19799953PubMed
1536,724,9463-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin.Biol Pharm Bull2023https://conductscience.org/library/papers/36724946PubMed
1621,237,233Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.Prog Neuropsychopharmacol Biol Psychiatry2011https://conductscience.org/library/papers/21237233PubMed
1732,998,277Neuroprotective Effect of Antioxidants in the Brain.Int J Mol Sci2020https://conductscience.org/library/papers/32998277PubMed
1835,988,447Mitochondrial and redox modifications in early stages of Huntington's disease.Redox Biol2022https://conductscience.org/library/papers/35988447PubMed
1929,427,098Mitochondrial Dysfunction in Huntington's Disease.Adv Exp Med Biol2018https://conductscience.org/library/papers/29427098PubMed
2035,974,214Research Progress of Long Non-coding RNAs in Spinal Cord Injury.Neurochem Res2023https://conductscience.org/library/papers/35974214PubMed

See all 132 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42,823,496Therapeutic role of fucoidans against oxidative stress: recent developments, translational challenges, and future directions.Arch Toxicol2026https://conductscience.org/library/papers/42823496PubMed
42,616,200The potential of vitamins in Huntington's disease: bridging mechanistic evidence with translational limitations and future strategies.Metab Brain Dis2026https://conductscience.org/library/papers/42616200PubMed
42,609,516Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.MedComm (2020)2026https://conductscience.org/library/papers/42609516PubMed
42,237,308Neuroprotective potential of esterified indole-3-propionic acid with curcumin against high glucose stress: targeting oxidative damage, Akt/mTOR, and BDNF/TrkB pathways.BMC Pharmacol Toxicol2026https://conductscience.org/library/papers/42237308PubMed
42,204,067Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances.Mol Biomed2026https://conductscience.org/library/papers/42204067PubMed
41,870,813Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches.Mol Neurobiol2026https://conductscience.org/library/papers/41870813PubMed
41,830,183Mechanisms and therapeutic potential of mitochondrial-targeted therapies in bone repair.Ann Med2026https://conductscience.org/library/papers/41830183PubMed
41,762,337
Roflumilast Elicits Therapeutic and Neuroprotective Effects in 3-Nitropropionic Acid-Induced Huntington's Disease-Like Neurodegeneration in Rats by Mitigating NLRP3 Inflammasome-Mediated Pyroptosis, Ferroptosis, and Glial Activation.
Neurochem Res2026https://conductscience.org/library/papers/41762337PubMed
41,720,188Unraveling Riboflavin-Mediated Mitochondrial Modulation as a Therapeutic Pathway in Neurological Disorders: An Integrative Systematic Review.J Nutr2026https://conductscience.org/library/papers/41720188PubMed
41,703,162Alisol A Mitigates Neuroinflammation and Oxidative Stress After Subarachnoid Hemorrhage Through SIRT3-Driven Reprogramming of Mitochondrial Metabolism.Mol Neurobiol2026https://conductscience.org/library/papers/41703162PubMed
41,693,955Dietary and metabolic reprogramming alleviates neurodegeneration: a review of mechanisms and clinical implications.Front Nutr2026https://conductscience.org/library/papers/41693955PubMed
41,420,771Piceatannol as a multi-target neuroprotective agent: mechanistic insights and therapeutic prospects in neurological disorders.Metab Brain Dis2025https://conductscience.org/library/papers/41420771PubMed
40,979,213Mitochondria-Associated Endoplasmic Reticulum Membranes in Health and Diseases.MedComm (2020)2025https://conductscience.org/library/papers/40979213PubMed
40,874,597Therapeutic strategies for Huntington's disease: current approaches and future direction.Neurodegener Dis Manag2026https://conductscience.org/library/papers/40874597PubMed
40,599,237Oxidative Stress: Signaling Pathways, Biological Functions, and Disease.MedComm (2020)2025https://conductscience.org/library/papers/40599237PubMed
40,295,342Advances in research on mitochondrial dysfunction in neurodegenerative diseases.J Neurol2025https://conductscience.org/library/papers/40295342PubMed
39,440,770Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases.Curr Neuropharmacol2025https://conductscience.org/library/papers/39440770PubMed
39,337,461New Insights into Mitochondria in Health and Diseases.Int J Mol Sci2024https://conductscience.org/library/papers/39337461PubMed
39,333,347TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential.Mol Neurobiol2025https://conductscience.org/library/papers/39333347PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNM1L10,059PubTator's text mininghttps://conductscience.org/library/genes/10059NCBI Gene
FIS151,024PubTator's text mininghttps://conductscience.org/library/genes/51024NCBI Gene
HTT3,064PubTator's text mininghttps://conductscience.org/library/genes/3064NCBI Gene
PPARGC1A10,891PubTator's text mininghttps://conductscience.org/library/genes/10891NCBI Gene
SIRT123,411PubTator's text mininghttps://conductscience.org/library/genes/23411NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38982016

GET https://conductscience.org/api/papers/v1/38982016/references?page=2